Marchex, Inc. Announces Executive and Director Changes

Ticker: MCHX · Form: 8-K · Filed: 2025-01-10T00:00:00.000Z

Sentiment: neutral

Topics: management-change, executive-compensation, board-of-directors

TL;DR

Marchex leadership shake-up: new directors elected, exec comp adjusted.

AI Summary

On January 10, 2025, Marchex, Inc. filed an 8-K report detailing changes in its executive and director positions. The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. Specific details regarding the individuals involved and the nature of the compensatory changes are outlined within the report.

Why It Matters

Changes in a company's leadership and executive compensation can signal shifts in strategy, operational focus, or financial outlook, impacting investor confidence and stock performance.

Risk Assessment

Risk Level: medium — Changes in executive and director roles can indicate internal shifts or strategic realignments that may carry inherent risks.

Key Numbers

Key Players & Entities

FAQ

What specific roles have been affected by the departures and appointments at Marchex, Inc.?

The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for certain officers, though specific names and roles are detailed within the full report.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated January 10, 2025.

What is the principal executive office address for Marchex, Inc.?

The principal executive offices are located at 1200 5th Ave, Suite 1300, Seattle, Washington 98101.

Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?

This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the SIC code for Marchex, Inc.?

The Standard Industrial Classification (SIC) code for Marchex, Inc. is 7389, categorized under SERVICES-BUSINESS SERVICES, NEC.

Filing Stats: 462 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-01-10 16:15:07

Filing Documents

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported): January 10, 2025 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1200 5 th Ave , Suite 1300 , Seattle , Washington 98101 (Address of principal executive offices) (Zip Code) Registrant's Telephone Number, Including Area Code: ( 206 ) 331-3300 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Class B Common Stock MCHX The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements for Certain Officers. On January 10, 2025, Marchex, Inc. (the "Company") announced the termination of employment of Holly Aglio ("Aglio"), Chief Financial Officer of the Company, effective as of that date. Aglio will receive severance benefits consistent with the terms disclosed in the Company's filings with the SEC. Aglio's departure from the Company is not due to any disagreement or dispute with the Company nor to any improprieties or misconduct. Brian Nagle, the Company's Senior Vice President/Corporate Controller, will be appointed as the Company's Principal Financial Officer and Principal Accounting Officer. Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. MARCHEX, INC. Date: January 10, 2025 By: /s/ FRANCIS J. FEENEY Name: Francis J. Feeney Title: Secretary

View on Read The Filing